HDAC9 and cancer: Thus, we concluded that differences in cell cycle arrest between UC cells and other cancer cell types after treatment with HDACi do not originate from cancer-specific genetic changes, but may rather be elicited by UC-specific functions of HDAC isoenzymes in the regulation of cell cycle and checkpoint control genes.